Associate Professor, Pathology-Brigham and Women's Hospital, Harvard Medical School

Pathology

Andrea L. Richardson, MD works in the field of Pathology. She researched medicine at University of Texas Southwestern Medical School. Doctor Andrea L. Richardson, MD is also published. She has 46 publications published. The lastest publication: "BRCA1 haploinsufficiency for replication stress suppression in primary cells.' She is registered with Medicare and accepts Medicare payments.

Publications

---

• Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis.
• Prospective clinical experience with research biopsies in breast cancer patients.
• Interobserver Concordance in Implementing the 2010 ASCO/CAP Recommendations for Reporting ER in Breast Carcinomas: A Demonstration of the Difficulties of Consistently ...
• MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling.
• Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
• Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27(+) Cell Population with Progenitor Characteristics.
• Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
• Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells.
• Sequence analysis of mutations and translocations across breast cancer subtypes.
• BEAMing Up Personalized Medicine: Mutation Detection in Blood.
• Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells.
• Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer.
• Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer.
• Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis.
• Paracrine and autocrine signals induce and maintain mesenchymal and stem cell States in the breast.
• The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors.
• Paradoxical Relationship between Chromosomal Instability and Survival Outcome in Cancer.
• Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.
• Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.
• Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.
• The transcription factor REST is lost in aggressive breast cancer.
• FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer.
• Subtle variations in Pten dose determine cancer susceptibility.
• Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
• Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer.
• Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER status.
• PTK6 regulates IGF-1-induced anchorage-independent survival.
• Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase.
• A comparison of estrogen receptor SP1 and 1D5 monoclonal antibodies in routine clinical use reveals similar staining results.
• Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.
• A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.
• SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis.
• Cell type-specific DNA methylation patterns in the human breast.
• CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization.
• Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes.
• Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
• Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers.
• Molecular definition of breast tumor heterogeneity.
• X chromosomal abnormalities in basal-like human breast cancer.
• Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
• Genomic approaches in cancer biology.
• Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations.
• Deconvoluting complex tissues for expression quantitative trait locus-based analyses.
• BRCA1 haploinsufficiency for replication stress suppression in primary cells.
• STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes.

Schools

---

• University of North Carolina At Chapel Hill

• University of Texas Southwestern Medical Center At Dallas

• Brigham and Women39s Hospital

Doctors Specialties

---

• Cytopathology
• Pathology

Accepted Insurances

---

Education

---

• Brigham and Women's Hospital
• University of Texas Southwestern Medical School

Hospital

---

• Johns Hopkins Hospital
• Johns Hopkins Bayview Medical Center
• Brigham and Women's Hospital

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1023069523
Last Name Of The Provider	RICHARDSON
First Name Of The Provider	ANDREA
View All

Similar Doctors

---

	Dr. Nancy L. Harris, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Vinay S. Mahajan, MB BS This Doctor is OpenDoctor Recommended.
	Dr. Siddhartha Jaiswal, MD This Doctor is OpenDoctor Recommended.
	Dr. Jason Schmidt, MD This Doctor is OpenDoctor Recommended.
	Dr. Mamta Gupta, MD
	Dr. Jeffery L. Kutok, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Vickie Y. Jo, MD This Doctor is OpenDoctor Recommended.
	Dr. Scott R. Granter, MD This Doctor is OpenDoctor Recommended.
	Dr. Rachel E. Factor, MD This Doctor is OpenDoctor Recommended.
	Dr. Veerle Bossuyt, MD This Doctor is OpenDoctor Recommended.
	Dr. Imad Ahmad Nasser, MD
	Dr. Jonathan L. Hecht, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jason L. Hornick, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Daniel W. Rust, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael J. O'Brien, MD
	Dr. Niall J. Mulligan, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog